Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SStoke Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

Stoke Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $9.33M. Net result −$61.62M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $9.33M. Running result $9.33M. Revenue: $9.33M.
  • Cost of revenue: $0. Running result $9.33M.
  • Gross profit: $9.33M. Running result $9.33M.
  • Research and development: −$49.5M. Running result −$40.18M.
  • Sales, general and administrative: −$25.25M. Running result −$65.43M.
  • Operating income: −$65.43M. Running result −$65.43M.
  • Other income: $3.81M. Running result −$61.62M.
  • Pre-tax loss: −$61.62M. Running result −$61.62M.
  • Income tax benefit: $0. Running result −$61.62M.
  • Net loss: −$61.62M. Running result −$61.62M.